Patent details

300070 Product Name: Eletriptanum, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder het hydrobromide.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300070
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0592438
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300070
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
55218
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/12/2000
Marketing Authorization Country:
Switzerland (CH)

2

Marketing Authorization Number:
PL 00057/0452
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/02/2001
Marketing Authorization Country:
United Kingdom (GB)

3

Marketing Authorization Number:
PL 00057/0453
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/02/2001
Marketing Authorization Country:
United Kingdom (GB)

4

Marketing Authorization Number:
PL 00057/0454
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/02/2001
Marketing Authorization Country:
United Kingdom (GB)

5

Marketing Authorization Number:
RVG 26578
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
28/06/2001
Marketing Authorization Country:
Netherlands (NL)

6

Marketing Authorization Number:
RVG 26579
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
28/06/2001
Marketing Authorization Country:
Netherlands (NL)

Dates

Filing date:
16/11/2001
First Marketing Authorization date:
14/12/2000
Grant date:
04/01/2002
Activation date:
08/10/2011
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
16/11/2001
SPC/SPC Extension Expiration Date:
13/12/2015
Lapsed By Expiration Date:
14/12/2015
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
16/11/2001
 
 

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, 10017-5755, New York, New York, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
16/11/2001
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Lapse or annulment

2

Bulletin Heading:
VRV
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Lapse or annulment

3

Bulletin Heading:
SPC
Journal edition number:
2011/43
Publication date:
26/10/2011
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2002/03
Publication date:
01/03/2002
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2002/02
Publication date:
01/02/2002
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
07/10/2015
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Thomson IP Management Services (Master Data)
Filing date Document type Document Description Number of pages File Type
19/09/2007 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /0/7/0/0/0/0400300070/docs/300070_1_incomingcorrespondencepaper20070919.pdf
11/06/2007 Outgoing Correspondence Outgoing Letter 3 PDF /0/7/0/0/0/0400300070/docs/300070_0_outgoingcorrespondence20070611.pdf
06/06/2007 General 1 PDF /0/7/0/0/0/0400300070/docs/300070_10_spc-documents20070606.pdf
06/06/2007 General 2 PDF /0/7/0/0/0/0400300070/docs/300070_11_spc-documents20070606.pdf
04/01/2002 Outgoing Correspondence Outgoing Letter 1 PDF /0/7/0/0/0/0400300070/docs/300070_2_outgoingcorrespondence20020104.pdf
04/01/2002 Outgoing Correspondence Outgoing Letter 1 PDF /0/7/0/0/0/0400300070/docs/300070_13_outgoingcorrespondence20020104.pdf
04/01/2002 Outgoing Correspondence Outgoing Letter 1 PDF /0/7/0/0/0/0400300070/docs/300070_14_outgoingcorrespondence20020104.pdf
30/11/2001 General 1 PDF /0/7/0/0/0/0400300070/docs/300070_12_spc-documents20011130.pdf
16/11/2001 General 3 PDF /0/7/0/0/0/0400300070/docs/300070_3_spc-documents20011116.pdf
16/11/2001 General 2 PDF /0/7/0/0/0/0400300070/docs/300070_4_spc-documents20011116.pdf
16/11/2001 General 10 PDF /0/7/0/0/0/0400300070/docs/300070_5_spc-documents20011116.pdf
16/11/2001 General 2 PDF /0/7/0/0/0/0400300070/docs/300070_6_spc-documents20011116.pdf
16/11/2001 General 2 PDF /0/7/0/0/0/0400300070/docs/300070_7_spc-documents20011116.pdf
16/11/2001 General 1 PDF /0/7/0/0/0/0400300070/docs/300070_8_spc-documents20011116.pdf
16/11/2001 General 3 PDF /0/7/0/0/0/0400300070/docs/300070_9_spc-documents20011116.pdf
16/11/2001 Application Form First filed application form 3 PDF /0/7/0/0/0/0400300070/docs/300070_15_applicationform20011116.pdf
16/11/2001 General 1 PDF /0/7/0/0/0/0400300070/docs/300070_16_spc-documents20011116.pdf